Correlation Between Sonoma Pharmaceuticals and Eagle Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonoma Pharmaceuticals and Eagle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonoma Pharmaceuticals and Eagle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonoma Pharmaceuticals and Eagle Pharmaceuticals, you can compare the effects of market volatilities on Sonoma Pharmaceuticals and Eagle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonoma Pharmaceuticals with a short position of Eagle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonoma Pharmaceuticals and Eagle Pharmaceuticals.

Diversification Opportunities for Sonoma Pharmaceuticals and Eagle Pharmaceuticals

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sonoma and Eagle is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and Eagle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eagle Pharmaceuticals and Sonoma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonoma Pharmaceuticals are associated (or correlated) with Eagle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eagle Pharmaceuticals has no effect on the direction of Sonoma Pharmaceuticals i.e., Sonoma Pharmaceuticals and Eagle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sonoma Pharmaceuticals and Eagle Pharmaceuticals

If you would invest  300.00  in Sonoma Pharmaceuticals on August 28, 2024 and sell it today you would lose (7.00) from holding Sonoma Pharmaceuticals or give up 2.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.55%
ValuesDaily Returns

Sonoma Pharmaceuticals  vs.  Eagle Pharmaceuticals

 Performance 
       Timeline  
Sonoma Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sonoma Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Sonoma Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Eagle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eagle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Sonoma Pharmaceuticals and Eagle Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonoma Pharmaceuticals and Eagle Pharmaceuticals

The main advantage of trading using opposite Sonoma Pharmaceuticals and Eagle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonoma Pharmaceuticals position performs unexpectedly, Eagle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eagle Pharmaceuticals will offset losses from the drop in Eagle Pharmaceuticals' long position.
The idea behind Sonoma Pharmaceuticals and Eagle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk